Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
Background In December, 2020, two mRNA-based COVID-19 vaccines were authorised for…
